Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level ll Quote
View:
Post by knoxt on Jan 07, 2022 12:25pm

Level ll Quote

 

THERALASE TECHNOLOGIES INC (CA: TLT)


          
Real-time  

Last: 0.330   Change: -0.020    Volume: 178,199   Last Trade: 10:58  

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.33 20000 3 $0.335 26500 1
$0.325 12500 2 $0.34 80000 2
$0.32 14500 2 $0.36 2500 1
$0.315 24500 3 $0.37 75000 2
$0.31 22000 4 $0.38 56500 9
$0.305 5000 1 $0.395 30000 1
$0.30 13500 1 $0.40 84500 6
$0.29 41000 1 $0.415 500 1
$0.285 27500 1 $0.42 15500 2
$0.28 15500 2 $0.425 7000 1
Comment by 99942Apophis on Jan 07, 2022 1:48pm
Thanks knoxt looks like another week is about to close in the thirties and building a solid base here. Expecting news at some point will validate this as a top treatment in cancer. Have a good weekend. 
Comment by menoalittle on Jan 07, 2022 4:17pm
it's actually a very nice bullish flag pattern developing... another week or two and it looks likely to make a(nother) strong breakout move 
Comment by 99942Apophis on Jan 07, 2022 4:36pm
menoalittle wrote  it's actually a very nice bullish flag pattern developing... another week or two and it looks likely to make a(nother) strong breakout move  Agreed menoalittle sure is a nice pattern being formed and yes when the next news release comes it will take us into that breakout.  In my biased opinion once we also get the next Newsletter it will propel us even ...more  
Comment by StevenBirch on Jan 07, 2022 8:17pm
It's almost like the chart knows that we are getting very close to what could be life altering news.
Comment by 99942Apophis on Jan 07, 2022 8:59pm
Good pun StevenBirch " life altering " for people with Bladder Cancer and will add a strong charge to our SP. I think most of us have that feeling around 95-99% of all patients after the first unfortunate 12 will have Complete Response (CR). I'm not worried in the slightest about the outcome thanks to all those at Theralase who worked so hard to perfect & improve this PH2 ...more  
Comment by Oilminerdeluxe on Jan 08, 2022 1:04am
If they intend to tell us if they have applied for, or will, that BTD, next week is a good time for that. If so, I suspect that a few more patients have been checked with CR. If it drags on, well maybe they weren't CR. But who knows. Just speculating.  Maybe they will not even tell us when they apply. Anyway, the next update should have a lot of data in it. 6 months for a bunch of people ...more  
Comment by StevenBirch on Jan 08, 2022 11:40am
Oil I wish you hadn't said "If it drags on, well maybe they weren't CR" because that just gives fuel to the guys who play around with this stock. Now they won't get any of my shares or many other people's here as well but there are some who are more nervous and vulnerable to the sell off days. Also, they have not said they will put out a news release when they apply so ...more  
Comment by Oilminerdeluxe on Jan 08, 2022 12:38pm
Steven, perhaps I should have been a bit more careful with my wording. My apologies. 2022 will be an interesting year no doubt. TLT could be a life changer for many of us.
Comment by StevenBirch on Jan 08, 2022 1:08pm
No apology needed and I didn't mean to sound critical, it's just that these manipulators don't need any help.
Comment by Oilminerdeluxe on Jan 08, 2022 1:18pm
Yes, I know what you mean. You should see the PYR board. The basher crowd is so sordid and disgusting that they twist every word to try and put the company in bad light. Vile creatures are everywhere it seems.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250